Showing results (631-640 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|March 19, 2026
The TNFR superfamily member Fn14 impacts immunity and survival in experimental gliomas and response to immune checkpoint inhibitor therapy in glioblastoma patientsPranjali P Kanvinde, Adarsha P Malla, Alexandra A Seas, et al.
Neuro-Oncology Advances|April 21, 2026
Beyond cell cycle control: CDKN2A loss is associated with altered NAD+ metabolic states and increased sensitivity to NAMPT inhibition in glioblastomaSwati Dubey, Guanqiao Yu, Ryana Aboul-Hosn, et al.
Neuro-Oncology Advances|April 22, 2026
CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomasShuodan Zhang, Byram H Ozer, Antonio Omuro, et al.
Neuro-Oncology Advances|April 10, 2026
Tumor recurrence patterns in eloquent glioma after microsurgical resection and adjuvant radiochemotherapyMaximilian Schwendner, Stefan Suvak, Sarah Stefanowicz, et al.
Neuro-Oncology Advances|May 18, 2026
A methylome-based score to predict survival after regorafenib in recurrent glioblastomaSilvia Chiesa, Evelina Miele, Sara Patrizi, et al.
Neuro-Oncology Advances|May 14, 2026
MGMTai: O6-methylguanine-DNA methyltransferase (MGMT) methylation prediction in isocitrate dehydrogenase (IDH)-wild type glioblastoma to direct temozolomide therapyPatricia Pittman, Chen Sun, Timothy Samec, et al.
Neuro-Oncology Advances|June 9, 2026
Educational needs in neuro-oncology: Insights from the European Society for Medical Oncology Central Nervous System Faculty SurveyOriol Mirallas, Giulia Cerretti, Anna Sophie Berghoff, et al.
Neuro-Oncology Advances|June 8, 2026
Combining the KRASG12C inhibitor adagrasib with anti-PD-1 immunotherapy improves overall survival and prevents recurrence in preclinical models of brain metastasisConsuelo Torrini, Naema Nayyar, Gregory R Wojtkiewicz, et al.
Neuro-Oncology Advances|June 11, 2026
Comparison of 2 stereotactic radiotherapy regimens for brain metastases: Is higher always better?Vincent Bourbonne, Moncef Morjani, Brieg Dissaux, et al.
Neuro-Oncology Advances|June 1, 2026
A common signature of brain metastases among patients with breast cancer, melanoma, and lymphomaThuy Thi Nguyen, Duc Manh Hoang, Tai Van Nguyen, et al.
Pageof 138